logo

For the Inventor, By the Inventor

Laytonsville, MD, United States of America

Matthews O Bradley

This inventor holds 14 USPTO granted patents. Top assignees: Neuromedica, Inc., Luitpold Pharmaceuticals, Inc., Protarga, Inc.. Active years: 1996-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthews O Bradley. Retrieved from https://idiyas.com/inventor/matthews-o-bradley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 85.7

Average Co-Inventor Count = 4.0

ph-index = 12

Forward Citations = 766(Granted Patents)


Location History:

  • Laytonville, MD (US) (1999)
  • Layton, PA (US) (2003)
  • Laytonsville, MD (US) (1996 - 2012)

Company Filing History:

goldMedal5 out of 9 
 
Neuromedica, Inc.
 patents
silverMedal3 out of 19 
 
Luitpold Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 8 
 
Protarga, Inc.
 patents
4. 3 out of 16,278 
 
USA as Represented by Secretary of the Navy
 patents

Years Active: 1996-2012

Loading Chart...
14 patents (USPTO):Explore Patents
1. 8314077 - Fatty acid-pharmaceutical agent conjugates (2012-11-20),
2. 7235583 - Fatty acid-anticancer conjugates and uses thereof (2007-06-26),
3. 7199151 - DHA-pharmaceutical agent conjugates of taxanes (2007-04-03),
4. 6602902 - Dha-pharmaceutical agent conjugates to improve tissue selectivity (2003-08-05),
5. 6576636 - Method of treating a liver disorder with fatty acid-antiviral agent conjugates (2003-06-10),
6. 6197764 - Clozapine compositions and uses thereof (2001-03-06),
7. 6080877 - Taxanes (2000-06-27),
8. 5977174 - Cholinergic compositions and uses thereof (1999-11-02),
9. 5955459 - Fatty acid-antipsychotic compositions and uses thereof (1999-09-21),
10. 5919815 - Taxane compounds and compositions (1999-07-06),
11. 5795909 - DHA-pharmaceutical agent conjugates of taxanes (1998-08-18),
12. 5596090 - Antisense oligonucleotides directed against human VCAM-1 RNA (1997-01-21),
13. 5585479 - Antisense oligonucleotides directed against human ELAM-I RNA (1996-12-17),
14. 5580969 - Antisense oligonucleotides directed against human ICAM-I RNA (1996-12-03),

Title: The Innovative Journey of Matthews O Bradley

Introduction: Matthews O Bradley, a distinguished inventor hailing from Laytonsville, MD, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Bradley's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device aimed at improving patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, Bradley has a proven track record of developing innovative solutions to complex problems. He has held key positions in various tech companies, leading teams to create cutting-edge products that have garnered international acclaim.

Collaborations: Bradley is known for his successful collaborations with leading research institutions and universities, where he has worked on projects that have pushed the boundaries of technological advancement. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Matthews O Bradley stands as a beacon of innovation in the tech industry, with a passion for creating solutions that have a lasting impact on society. His relentless pursuit of excellence and commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…